John D. Ratliff
2019 - Laboratory Corp. of America Holdings
In 2019, John D. Ratliff earned a total compensation of $4.6M as Former Executive Vice President, Chief Executive Officer of Covance Drug Development at Laboratory Corp. of America Holdings, a 39% decrease compared to previous year.
Compensation breakdown
| Option Awards | $749,996 |
|---|---|
| Salary | $582,631 |
| Stock Awards | $3,199,516 |
| Other | $37,326 |
| Total | $4,569,469 |
Ratliff received $3.2M in stock awards, accounting for 70% of the total pay in 2019.
Ratliff also received $750K in option awards, $582.6K in salary and $37.3K in other compensation.
Rankings
In 2019, John D. Ratliff's compensation ranked 2,494th out of 13,971 executives tracked by ExecPay. In other words, Ratliff earned more than 82.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,494 out of 13,971 | 82nd |
Division Services | 544 out of 2,396 | 77th |
Major group Health Services | 47 out of 242 | 81st |
Industry group Medical And Dental Laboratories | 9 out of 75 | 88th |
Industry Medical Laboratories | 9 out of 75 | 88th |
Source: SEC filing on April 1, 2020.
Ratliff's colleagues
We found six more compensation records of executives who worked with John D. Ratliff at Laboratory Corp. of America Holdings in 2019.
2019
DAVID KING
Laboratory Corp. of America Holdings
Chief Executive Officer
2019
GLENN EISENBERG
Laboratory Corp. of America Holdings
Chief Financial Officer
2019
Adam Schechter
Laboratory Corp. of America Holdings
Chief Executive Officer
2019
Brian Caveney
Laboratory Corp. of America Holdings
Chief Medical Officer
2019
LANCE BERBERIAN
Laboratory Corp. of America Holdings
Executive Vice President Chief Information and Technology Officer
2019
Mark Schroeder
Laboratory Corp. of America Holdings